Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy

Yuejin Li, Pierre Yves Jean Charles, Changlong Nan, Jose Renato Pinto, Yingcai Wang, Jingsheng Liang, Gang Wu, Jie Tian, Han Zhong Feng, James D. Potter, J. P. Jin, Xupei Huang

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Several cardiac troponin I (cTnI) mutations are associated with restrictive cardiomyopathy (RCM) in humans. We have created transgenic mice (cTnI193His mice) that express the corresponding human RCM R192H mutation. Phenotype of this RCM animal model includes restrictive ventricles, biatrial enlargement and sudden cardiac death, which are similar to those observed in RCM patients carrying the same cTnI mutation. In the present study, we modified the overall cTnI in cardiac muscle by crossing cTnI193His mice with transgenic mice expressing an N-terminal truncated cTnI (cTnI-ND) that enhances relaxation. Protein analyses determined that wild type cTnI was replaced by cTnI-ND in the heart of double transgenic mice (Double TG), which express only cTnI-ND and cTnI R193H in cardiac myocytes. The presence of cTnI-ND effectively rescued the lethal phenotype of RCM mice by reducing the mortality rate. Cardiac function was significantly improved in Double TG mice when measured by echocardiography. The hypersensitivity to Ca2+ and the prolonged relaxation of RCM cTnI193His cardiac myocytes were completely reversed by the presence of cTnI-ND in RCM hearts. The results demonstrate that myofibril hypersensitivity to Ca2+ is a key mechanism that causes impaired relaxation in RCM cTnI mutant hearts and Ca2+ desensitization by cTnI-ND can correct diastolic dysfunction and rescue the RCM phenotypes, suggesting that Ca2+ desensitization in myofibrils is a therapeutic option for treatment of diastolic dysfunction without interventions directed at the systemic β-adrenergic-PKA pathways.

Original languageEnglish
Pages (from-to)402-411
Number of pages10
JournalJournal of Molecular and Cellular Cardiology
Volume49
Issue number3
DOIs
StatePublished - Sep 1 2010

Fingerprint

Restrictive Cardiomyopathy
Troponin
Troponin I
Transgenic Mice
Myofibrils
Phenotype
Cardiac Myocytes
Mutation
Hypersensitivity
Sudden Cardiac Death

Keywords

  • Ca desensitization
  • Diastolic dysfunction
  • RCM
  • Transgenic mice
  • Troponin

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy. / Li, Yuejin; Charles, Pierre Yves Jean; Nan, Changlong; Pinto, Jose Renato; Wang, Yingcai; Liang, Jingsheng; Wu, Gang; Tian, Jie; Feng, Han Zhong; Potter, James D.; Jin, J. P.; Huang, Xupei.

In: Journal of Molecular and Cellular Cardiology, Vol. 49, No. 3, 01.09.2010, p. 402-411.

Research output: Contribution to journalArticle

Li, Y, Charles, PYJ, Nan, C, Pinto, JR, Wang, Y, Liang, J, Wu, G, Tian, J, Feng, HZ, Potter, JD, Jin, JP & Huang, X 2010, 'Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy', Journal of Molecular and Cellular Cardiology, vol. 49, no. 3, pp. 402-411. https://doi.org/10.1016/j.yjmcc.2010.04.017
Li, Yuejin ; Charles, Pierre Yves Jean ; Nan, Changlong ; Pinto, Jose Renato ; Wang, Yingcai ; Liang, Jingsheng ; Wu, Gang ; Tian, Jie ; Feng, Han Zhong ; Potter, James D. ; Jin, J. P. ; Huang, Xupei. / Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy. In: Journal of Molecular and Cellular Cardiology. 2010 ; Vol. 49, No. 3. pp. 402-411.
@article{a613362dfd224545be47749d6d836484,
title = "Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy",
abstract = "Several cardiac troponin I (cTnI) mutations are associated with restrictive cardiomyopathy (RCM) in humans. We have created transgenic mice (cTnI193His mice) that express the corresponding human RCM R192H mutation. Phenotype of this RCM animal model includes restrictive ventricles, biatrial enlargement and sudden cardiac death, which are similar to those observed in RCM patients carrying the same cTnI mutation. In the present study, we modified the overall cTnI in cardiac muscle by crossing cTnI193His mice with transgenic mice expressing an N-terminal truncated cTnI (cTnI-ND) that enhances relaxation. Protein analyses determined that wild type cTnI was replaced by cTnI-ND in the heart of double transgenic mice (Double TG), which express only cTnI-ND and cTnI R193H in cardiac myocytes. The presence of cTnI-ND effectively rescued the lethal phenotype of RCM mice by reducing the mortality rate. Cardiac function was significantly improved in Double TG mice when measured by echocardiography. The hypersensitivity to Ca2+ and the prolonged relaxation of RCM cTnI193His cardiac myocytes were completely reversed by the presence of cTnI-ND in RCM hearts. The results demonstrate that myofibril hypersensitivity to Ca2+ is a key mechanism that causes impaired relaxation in RCM cTnI mutant hearts and Ca2+ desensitization by cTnI-ND can correct diastolic dysfunction and rescue the RCM phenotypes, suggesting that Ca2+ desensitization in myofibrils is a therapeutic option for treatment of diastolic dysfunction without interventions directed at the systemic β-adrenergic-PKA pathways.",
keywords = "Ca desensitization, Diastolic dysfunction, RCM, Transgenic mice, Troponin",
author = "Yuejin Li and Charles, {Pierre Yves Jean} and Changlong Nan and Pinto, {Jose Renato} and Yingcai Wang and Jingsheng Liang and Gang Wu and Jie Tian and Feng, {Han Zhong} and Potter, {James D.} and Jin, {J. P.} and Xupei Huang",
year = "2010",
month = "9",
day = "1",
doi = "10.1016/j.yjmcc.2010.04.017",
language = "English",
volume = "49",
pages = "402--411",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy

AU - Li, Yuejin

AU - Charles, Pierre Yves Jean

AU - Nan, Changlong

AU - Pinto, Jose Renato

AU - Wang, Yingcai

AU - Liang, Jingsheng

AU - Wu, Gang

AU - Tian, Jie

AU - Feng, Han Zhong

AU - Potter, James D.

AU - Jin, J. P.

AU - Huang, Xupei

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Several cardiac troponin I (cTnI) mutations are associated with restrictive cardiomyopathy (RCM) in humans. We have created transgenic mice (cTnI193His mice) that express the corresponding human RCM R192H mutation. Phenotype of this RCM animal model includes restrictive ventricles, biatrial enlargement and sudden cardiac death, which are similar to those observed in RCM patients carrying the same cTnI mutation. In the present study, we modified the overall cTnI in cardiac muscle by crossing cTnI193His mice with transgenic mice expressing an N-terminal truncated cTnI (cTnI-ND) that enhances relaxation. Protein analyses determined that wild type cTnI was replaced by cTnI-ND in the heart of double transgenic mice (Double TG), which express only cTnI-ND and cTnI R193H in cardiac myocytes. The presence of cTnI-ND effectively rescued the lethal phenotype of RCM mice by reducing the mortality rate. Cardiac function was significantly improved in Double TG mice when measured by echocardiography. The hypersensitivity to Ca2+ and the prolonged relaxation of RCM cTnI193His cardiac myocytes were completely reversed by the presence of cTnI-ND in RCM hearts. The results demonstrate that myofibril hypersensitivity to Ca2+ is a key mechanism that causes impaired relaxation in RCM cTnI mutant hearts and Ca2+ desensitization by cTnI-ND can correct diastolic dysfunction and rescue the RCM phenotypes, suggesting that Ca2+ desensitization in myofibrils is a therapeutic option for treatment of diastolic dysfunction without interventions directed at the systemic β-adrenergic-PKA pathways.

AB - Several cardiac troponin I (cTnI) mutations are associated with restrictive cardiomyopathy (RCM) in humans. We have created transgenic mice (cTnI193His mice) that express the corresponding human RCM R192H mutation. Phenotype of this RCM animal model includes restrictive ventricles, biatrial enlargement and sudden cardiac death, which are similar to those observed in RCM patients carrying the same cTnI mutation. In the present study, we modified the overall cTnI in cardiac muscle by crossing cTnI193His mice with transgenic mice expressing an N-terminal truncated cTnI (cTnI-ND) that enhances relaxation. Protein analyses determined that wild type cTnI was replaced by cTnI-ND in the heart of double transgenic mice (Double TG), which express only cTnI-ND and cTnI R193H in cardiac myocytes. The presence of cTnI-ND effectively rescued the lethal phenotype of RCM mice by reducing the mortality rate. Cardiac function was significantly improved in Double TG mice when measured by echocardiography. The hypersensitivity to Ca2+ and the prolonged relaxation of RCM cTnI193His cardiac myocytes were completely reversed by the presence of cTnI-ND in RCM hearts. The results demonstrate that myofibril hypersensitivity to Ca2+ is a key mechanism that causes impaired relaxation in RCM cTnI mutant hearts and Ca2+ desensitization by cTnI-ND can correct diastolic dysfunction and rescue the RCM phenotypes, suggesting that Ca2+ desensitization in myofibrils is a therapeutic option for treatment of diastolic dysfunction without interventions directed at the systemic β-adrenergic-PKA pathways.

KW - Ca desensitization

KW - Diastolic dysfunction

KW - RCM

KW - Transgenic mice

KW - Troponin

UR - http://www.scopus.com/inward/record.url?scp=77955277222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955277222&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2010.04.017

DO - 10.1016/j.yjmcc.2010.04.017

M3 - Article

C2 - 20580639

AN - SCOPUS:77955277222

VL - 49

SP - 402

EP - 411

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 3

ER -